Articles
15 January 2008

Daily Assessment of Pain in Adults with Sickle Cell Disease

Publication: Annals of Internal Medicine
Volume 148, Number 2

Abstract

Background:

Researchers of sickle cell disease have traditionally used health care utilization as a proxy for pain and underlying vaso-occlusion. However, utilization may not completely reflect the amount of self-reported pain or acute, painful episodes (crises).

Objective:

To examine the prevalence of self-reported pain and the relationship among pain, crises, and utilization in adults with sickle cell disease.

Design:

Prospective cohort study.

Setting:

Academic and community practices in Virginia.

Patients:

232 patients age 16 years or older with sickle cell disease.

Measurements:

Patients completed a daily diary for up to 6 months, recording their maximum pain (on a scale of 0 to 9); whether they were in a crisis (crisis day); and whether they used hospital, emergency, or unscheduled ambulatory care for pain on the previous day (utilization day). Summary measures included both simple proportions and adjusted probabilities (for repeated measures within patients) of pain days, crisis days, and utilization days, as well as mean pain intensity.

Results:

Pain (with or without crisis or utilization of care) was reported on 54.5% of 31 017 analyzed patient-days (adjusted probability, 56%). Crises without utilization were reported on 12.7% of days and utilization on only 3.5% (unadjusted). In total, 29.3% of patients reported pain in greater than 95% of diary days, whereas only 14.2% reported pain in 5% or fewer diary days (adjusted). The frequency of home opiate use varied and independently predicted pain, crises, and utilization. Mean pain intensity on crisis days, noncrisis pain days, and total pain days increased as the percentage of pain days increased (P < 0.001). Intensity was significantly higher on utilization days (P < 0.001). However, utilization was not an independent predictor of crisis, after controlling for pain intensity.

Limitations:

The study was done in a single state. Patients did not always send in their diaries.

Conclusion:

Pain in adults with sickle cell disease is the rule rather than the exception and is far more prevalent and severe than previous large-scale studies have portrayed. It is mostly managed at home; therefore, its prevalence is probably underestimated by health care providers, resulting in misclassification, distorted communication, and undertreatment.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Serjeant GRSerjeant BE. Management of sickle cell disease; lessons from the Jamaican Cohort Study. Blood Rev. 1993;7:137-45. [PMID: 8241829]
2.
Serjeant GR. Sickle-cell disease. Lancet. 1997;350:725-30. [PMID: 9291916]
3.
Michaels LAOhene-Frempong KZhao HDouglas SD. Serum levels of substance P are elevated in patients with sickle cell disease and increase further during vaso-occlusive crisis. Blood. 1998;92:3148-51. [PMID: 9787150]
4.
Graido-Gonzalez EDoherty JCBergreen EWOrgan GTelfer MMcMillen MA. Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis. Blood. 1998;92:2551-5. [PMID: 9746797]
5.
Steinberg MH. Management of sickle cell disease. N Engl J Med. 1999;340:1021-30. [PMID: 10099145]
6.
Kaul DKFabry MENagel RL. Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: pathophysiological implications. Proc Natl Acad Sci U S A. 1989;86:3356-60. [PMID: 2497465]
7.
Hebbel RPBoogaerts MAEaton JWSteinberg MH. Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity. N Engl J Med. 1980;302:992-5. [PMID: 7366623]
8.
Setty BNStuart MJDampier CBrodecki DAllen JL. Hypoxaemia in sickle cell disease: biomarker modulation and relevance to pathophysiology. Lancet. 2003;362:1450-5. [PMID: 14602439]
9.
Kaul DKLiu XDFabry MENagel RL. Impaired nitric oxide-mediated vasodilation in transgenic sickle mouse. Am J Physiol Heart Circ Physiol. 2000;278:H1799-806. [PMID: 10843875]
10.
Reiter CDWang XTanus-Santos JEHogg NCannon RO 3rdSchechter ANet al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med. 2002;8:1383-9. [PMID: 12426562]
11.
Gladwin MTSchechter ANOgnibene FPColes WAReiter CDSchenke WHet al. Divergent nitric oxide bioavailability in men and women with sickle cell disease. Circulation. 2003;107:271-8. [PMID: 12538427]
12.
Sakhalkar VSRao SPWeedon JMiller ST. Elevated plasma sVCAM-1 levels in children with sickle cell disease: impact of chronic transfusion therapy. Am J Hematol. 2004;76:57-60. [PMID: 15114598]
13.
Platt OSBrambilla DJRosse WFMilner PFCastro OSteinberg MHet al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330:1639-44. [PMID: 7993409]
14.
Ballas SK. Pain management of sickle cell disease. Hematol Oncol Clin North Am. 2005;19:785-802, v. [PMID: 16214644]
15.
Smith WRBovbjerg VEPenberthy LTMcClish DKLevenson JLRoberts JDet al. Understanding pain and improving management of sickle cell disease: the PiSCES study. J Natl Med Assoc. 2005;97:183-93. [PMID: 15712781]
16.
McClish DKLevenson JLPenberthy LTRoseff SDBovbjerg VERoberts JDet al. Gender differences in pain and healthcare utilization for adult sickle cell patients: The PiSCES Project. J Womens Health (Larchmt). 2006;15:146-54. [PMID: 16536678]
17.
Charache STerrin MLMoore RDDover GJMcMahon RPBarton FBet al. Design of the multicenter study of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea. Control Clin Trials. 1995;16:432-46. [PMID: 8925656]
18.
Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med. 1997;337:762-9. [PMID: 9287233]
19.
El Nemer WWautier MPRahuel CGane PHermand PGalactéros Fet al. Endothelial Lu/BCAM glycoproteins are novel ligands for red blood cell alpha4beta1 integrin: role in adhesion of sickle red blood cells to endothelial cells. Blood. 2007;109:3544-51. [PMID: 17158232]
20.
Powars DRChan LSHiti ARamicone EJohnson C. Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine (Baltimore). 2005;84:363-76. [PMID: 16267411]
21.
Blum AYeganeh SPeleg AVigder FKryuger KKhatib Aet al. Endothelial function in patients with sickle cell anemia during and after sickle cell crises. J Thromb Thrombolysis. 2005;19:83-6. [PMID: 16052296]
22.
Dampier CSetty BNEggleston BBrodecki DO'Neal PStuart M. Vaso-occlusion in children with sickle cell disease: clinical characteristics and biologic correlates. J Pediatr Hematol Oncol. 2004;26:785-90. [PMID: 15591896]
23.
Wagner MC, Eckman JR, Wick TM. Sickle cell adhesion depends on hemodynamics and endothelial activation. J Lab Clin Med. 2004;144:260-7; discussion 227-8. [ 15570244]
24.
Hermann CHohmeister JDemirakça SZohsel KFlor H. Long-term alteration of pain sensitivity in school-aged children with early pain experiences. Pain. 2006;125:278-85. [PMID: 17011707]
25.
Dimcevski GSchipper KPTage-Jensen UFunch-Jensen PKrarup ALToft Eet al. Hypoalgesia to experimental visceral and somatic stimulation in painful chronic pancreatitis. Eur J Gastroenterol Hepatol. 2006;18:755-64. [PMID: 16772833]
26.
Ji RRKohno TMoore KAWoolf CJ. Central sensitization and LTP: do pain and memory share similar mechanisms? Trends Neurosci. 2003;26:696-705. [PMID: 14624855]
27.
Baron MJMcDonald PW. Significant pain reduction in chronic pain patients after detoxification from high-dose opioids. J Opioid Manag. 2006;2:277-82. [PMID: 17319259]
28.
Andersen R. A Behavioral model of families' use of health services: HSA studies. Chicago: Center for Health Administration Studies; 1968. University of Chicago Research Series no. 25.
29.
Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977;196:129-36. [PMID: 847460]
30.
Becker MH. The health belief model and personal health behavior. Health Education Monographs. 1974;2:409-19.
31.
Chen MMLand K. Testing the health belief model: LISREL analysis of alternative models of causal relationships between health beliefs and preventive dental behavior. Social Psychology Quarterly. 1986;49:45-60.
32.
Murray NMay A. Painful crises in sickle cell disease—patients' perspectives. BMJ. 1988;297:452-4. [PMID: 3139140]
33.
Bobo LMiller STSmith WRElam JTRosmarin PCLancaster DJ. Health perceptions and medical care opinions of inner-city adults with sickle cell disease or asthma compared with those of their siblings. South Med J. 1989;82:9-12. [PMID: 2911768]
34.
Elander JLusher JBevan DTelfer PBurton B. Understanding the causes of problematic pain management in sickle cell disease: evidence that pseudoaddiction plays a more important role than genuine analgesic dependence. J Pain Symptom Manage. 2004;27:156-69. [PMID: 15157040]
35.
Lefebvre JCKeefe FJ. Memory for pain: the relationship of pain catastrophizing to the recall of daily rheumatoid arthritis pain. Clin J Pain. 2002;18:56-63. [PMID: 11803304]
36.
Anie KASteptoe A. Pain, mood and opioid medication use in sickle cell disease. Hematol J. 2003;4:71-3. [PMID: 12692524]
37.
Reese FLSmith WR. Psychosocial determinants of health care utilization in sickle cell disease patients. Ann Behav Med. 1997;19:171-8. [PMID: 9603692]
38.
Shapiro BSDinges DFOrne ECBauer NReilly LBWhitehouse WGet al. Home management of sickle cell-related pain in children and adolescents: natural history and impact on school attendance. Pain. 1995;61:139-44. [PMID: 7644237]
39.
Fuggle PShand PAGill LJDavies SC. Pain, quality of life, and coping in sickle cell disease. Arch Dis Child. 1996;75:199-203. [PMID: 8976657]
40.
Gil KMCarson JWPorter LSReady JValrie CRedding-Lallinger Ret al. Daily stress and mood and their association with pain, health-care use, and school activity in adolescents with sickle cell disease. J Pediatr Psychol. 2003;28:363-73. [PMID: 12808013]
41.
Gil KMPorter LSReady JWorkman ESedway JAAnthony KK. Pain in children and adolescents with sickle cell disease: an analysis of daily pain diaries. Children's Health Care. 2000;29:225-41.
42.
Westerman MPBailey KFreels SSchlegel RWilliamson P. Assessment of painful episode frequency in sickle-cell disease. Am J Hematol. 1997;54:183-8. [PMID: 9067495]
43.
Gil KMCarson JWPorter LSScipio CBediako SMOrringer E. Daily mood and stress predict pain, health care use, and work activity in African American adults with sickle-cell disease. Health Psychol. 2004;23:267-74. [PMID: 15099167]
44.
Porter LSGil KMSedway JAReady JWorkman EThompson RJ Jr. Pain and stress in sickle cell disease: an analysis of daily pain records. Int J Behav Med. 1998;5:185-203. [PMID: 16250701]
45.
Allen KDGolightly YMOlsen MK. Pilot study of pain and coping among patients with osteoarthritis: a daily diary analysis. J Clin Rheumatol. 2006;12:118-23. [PMID: 16755238]
46.
Platt OSThorington BDBrambilla DJMilner PFRosse WFVichinsky Eet al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med. 1991;325:11-6. [PMID: 1710777]
47.
Charache STerrin MLMoore RDDover GJBarton FBEckert SVet al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med. 1995;332:1317-22. [PMID: 7715639]
48.
Steinberg MHBarton FCastro OPegelow CHBallas SKKutlar Aet al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA. 2003;289:1645-51. [PMID: 12672732]
49.
Von Korff MJensen MPKaroly P. Assessing global pain severity by self-report in clinical and health services research. Spine. 2000;25:3140-51. [PMID: 11124730]
50.
Shapiro BSBenjamin LJPayne RHeidrich G. Sickle cell-related pain: perceptions of medical practitioners. J Pain Symptom Manage. 1997;14:168-74. [PMID: 9291703]

Comments

0 Comments
Sign In to Submit A Comment